This consensus statement expands and integrates current guideline recommendations on antithrombotic strategies for patients with diabetes across various cardiovascular settings.
No takes yet. Share an insight, caveat, or question.
Integrates antithrombotic and glucose-lowering strategies for diabetes; extends prior recommendations across primary and secondary CV settings.
Patti et al. (2018) conducted a review in Diabetes mellitus and cardiovascular disease. Antithrombotic therapies and glucose-lowering drugs was evaluated. This consensus statement provides up-to-date recommendations on primary and secondary prevention of atherothrombotic events in patients with diabetes using antithrombotic and glucose-lowering drugs.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: